Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Avantor, Inc. (AVTR)

Dingemans Simon — Director
May 1, 2026
Purchase
Shares
25,000
Price
$8.14
Total Value
$203.50K
Shares Held After
25,000
% of Holdings
100.0%
May 1, 2026
Sale
Shares
1,220,376
Price
$149.84
Total Value
$182.86M
Shares Held After
28,880,209
% of Holdings
4.1%
May 1, 2026
Sale
Shares
17,096
Price
$24.99
Total Value
$427.23K
Shares Held After
68,188
% of Holdings
20.0%

CERUS CORP (CERS)

Jayaraman Vivek K — Chief Operating Officer
May 1, 2026
Sale
Shares
16,667
Price
$3.00
Total Value
$50.00K
Shares Held After
1,673,374
% of Holdings
1.0%
May 1, 2026
Sale
Shares
5,467
Price
$18.92
Total Value
$103.45K
Shares Held After
600,004
% of Holdings
0.9%

Butterfly Network, Inc. (BFLY)

Carlson Megan — CAO and SVP, Finance
May 1, 2026
Sale
Shares
110,422
Price
$4.75
Total Value
$524.39K
Shares Held After
507,209
% of Holdings
17.9%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
May 1, 2026
Sale
Shares
5,795
Price
$6.01
Total Value
$34.83K
Shares Held After
271,774
% of Holdings
2.1%
May 1, 2026
Sale
Shares
1,625
Price
$63.48
Total Value
$103.16K
Shares Held After
38,498
% of Holdings
4.1%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
May 1, 2026
Sale
Shares
1,104
Price
$425.02
Total Value
$469.22K
Shares Held After
20,729
% of Holdings
5.1%
May 1, 2026
Sale
Shares
21,097
Price
$54.04
Total Value
$1.14M
Shares Held After
65,623
% of Holdings
24.3%
May 1, 2026
Sale
Shares
37,327
Price
$53.52
Total Value
$2.00M
Shares Held After
86,720
% of Holdings
30.1%
May 1, 2026
Sale
Shares
1,431
Price
$74.45
Total Value
$106.53K
Shares Held After
11,014
% of Holdings
11.5%
May 1, 2026
Sale
Shares
8,680
Price
$73.35
Total Value
$636.70K
Shares Held After
12,445
% of Holdings
41.1%

Nuvalent, Inc. (NUVL)

Balcom Alexandra — Chief Financial Officer
May 1, 2026
Sale
Shares
124
Price
$99.97
Total Value
$12.40K
Shares Held After
85,533
% of Holdings
0.1%

Nuvalent, Inc. (NUVL)

Balcom Alexandra — Chief Financial Officer
May 1, 2026
Sale
Shares
7,434
Price
$99.29
Total Value
$738.12K
Shares Held After
85,657
% of Holdings
8.0%

Nuvalent, Inc. (NUVL)

Balcom Alexandra — Chief Financial Officer
May 1, 2026
Sale
Shares
3,872
Price
$98.42
Total Value
$381.08K
Shares Held After
93,091
% of Holdings
4.0%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
May 1, 2026
Sale
Shares
2,243
Price
$32.79
Total Value
$73.55K
Shares Held After
36,621
% of Holdings
5.8%
May 1, 2026
Sale
Shares
6,000
Price
$203.33
Total Value
$1.22M
Shares Held After
378,682
% of Holdings
1.6%
May 1, 2026
Sale
Shares
40,000
Price
$50.10
Total Value
$2.00M
Shares Held After
2,878,326
% of Holdings
1.4%

Pharvaris N.V. (PHVS)

Lu Peng — Chief Medical Officer
May 1, 2026
Sale
Shares
143
Price
$31.00
Total Value
$4.43K
Shares Held After
66,083
% of Holdings
0.2%

Pharvaris N.V. (PHVS)

Lu Peng — Chief Medical Officer
May 1, 2026
Sale
Shares
14,023
Price
$30.16
Total Value
$422.99K
Shares Held After
66,226
% of Holdings
17.5%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
800
Price
$234.02
Total Value
$187.21K
Shares Held After
41,382
% of Holdings
1.9%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
1,420
Price
$232.92
Total Value
$330.75K
Shares Held After
42,182
% of Holdings
3.3%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
780
Price
$232.04
Total Value
$180.99K
Shares Held After
43,602
% of Holdings
1.8%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
370
Price
$230.87
Total Value
$85.42K
Shares Held After
44,382
% of Holdings
0.8%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
98
Price
$229.71
Total Value
$22.51K
Shares Held After
44,752
% of Holdings
0.2%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
932
Price
$228.75
Total Value
$213.20K
Shares Held After
44,850
% of Holdings
2.0%

LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew — CLO & Secretary
May 1, 2026
Sale
Shares
600
Price
$227.45
Total Value
$136.47K
Shares Held After
45,782
% of Holdings
1.3%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
May 1, 2026
Sale
Shares
289
Price
$83.16
Total Value
$24.03K
Shares Held After
173,371
% of Holdings
0.2%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
May 1, 2026
Sale
Shares
900
Price
$82.60
Total Value
$74.34K
Shares Held After
173,660
% of Holdings
0.5%

Apogee Therapeutics, Inc. (APGE)

Henderson Jane — Chief Financial Officer
May 1, 2026
Sale
Shares
811
Price
$81.02
Total Value
$65.71K
Shares Held After
174,560
% of Holdings
0.5%

Ceribell, Inc. (CBLL)

Woo Raymond — Chief Technology Officer
May 1, 2026
Sale
Shares
6,611
Price
$20.45
Total Value
$135.19K
Shares Held After
197,648
% of Holdings
3.2%

Ceribell, Inc. (CBLL)

Woo Raymond — Chief Technology Officer
May 1, 2026
Sale
Shares
3,024
Price
$20.43
Total Value
$61.78K
Shares Held After
197,648
% of Holdings
1.5%

Ceribell, Inc. (CBLL)

Woo Raymond — Chief Technology Officer
May 1, 2026
Sale
Shares
1,469
Price
$20.39
Total Value
$29.95K
Shares Held After
197,648
% of Holdings
0.7%
May 1, 2026
Sale
Shares
1,000
Price
$82.99
Total Value
$82.99K
Shares Held After
33,934
% of Holdings
2.9%
May 1, 2026
Sale
Shares
19
Price
$83.99
Total Value
$1.60K
Shares Held After
34,934
% of Holdings
0.1%

GLAUKOS Corp (GKOS)

WEN LEANA — Director
May 1, 2026
Sale
Shares
1,700
Price
$143.35
Total Value
$243.69K
Shares Held After
19,739
% of Holdings
7.9%

GLAUKOS Corp (GKOS)

Gilliam Joseph E — PRESIDENT & COO
May 1, 2026
Sale
Shares
19,573
Price
$143.54
Total Value
$2.81M
Shares Held After
73,419
% of Holdings
21.0%
Shares
25,984
Price
$71.18
Total Value
$1.85M
Shares Held After
1,040,255
% of Holdings
2.4%
Shares
41,265
Price
$70.52
Total Value
$2.91M
Shares Held After
1,066,239
% of Holdings
3.7%
May 1, 2026
Sale
Shares
58,394
Price
$0.73
Total Value
$42.63K
Shares Held After
1,727,293
% of Holdings
3.3%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
May 1, 2026
Sale
Shares
4,683
Price
$24.90
Total Value
$116.61K
Shares Held After
110,342
% of Holdings
4.1%
May 1, 2026
Sale
Shares
144,180
Price
$34.99
Total Value
$5.05M
Shares Held After
80,760
% of Holdings
64.1%

Moderna, Inc. (MRNA)

Hussain Abbas — Director
May 1, 2026
Sale
Shares
5,682
Price
$46.63
Total Value
$264.95K
Shares Held After
12,066
% of Holdings
32.0%
May 1, 2026
Sale
Shares
954
Price
$8.96
Total Value
$8.55K
Shares Held After
129,721
% of Holdings
0.7%
May 1, 2026
Sale
Shares
14,527
Price
$8.36
Total Value
$121.45K
Shares Held After
130,675
% of Holdings
10.0%
May 1, 2026
Sale
Shares
1,057
Price
$8.97
Total Value
$9.48K
Shares Held After
79,941
% of Holdings
1.3%
May 1, 2026
Sale
Shares
16,145
Price
$8.36
Total Value
$134.97K
Shares Held After
80,998
% of Holdings
16.6%
May 1, 2026
Sale
Shares
980
Price
$8.94
Total Value
$8.76K
Shares Held After
100,563
% of Holdings
1.0%
May 1, 2026
Sale
Shares
12,781
Price
$8.36
Total Value
$106.85K
Shares Held After
101,543
% of Holdings
11.2%
Version: v26.5.2